For Professionals

Explore This Site.

For Others

For Industry Professionals and Others.

For Patients and Families

For Patients and Families.

INTERNATIONAL PEDIATRIC MULTIPLE SCLEROSIS STUDY GROUP (IPMSSG) For Medical Professionals

About
- History
- Contact
Membership
Events
Education
MS Care
Demyelinating Diseases

Menu

London 2016- Current Challenges in POMS

London 2016- Current Challenges in POMS

September 13, 2016 8:45 am

London meeting attendees

Final programme - 13 September meeting

Google Calendar

More about London 2016- Current Challenges in POMS

View full calendar

Post navigation

← International Pediatric MS Study Group…

International MS Societies

Multiple Sclerosis International Federation

Find MS Support Near You (from the MSIF)

Pediatric Multiple Sclerosis Clinical Trials and Studies

Discover clinical trials and research studies that are currently recruiting!

Including these (and many others):

Ongoing:

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

Adherence in Pediatric Multiple Sclerosis
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients with RRMP With Disease Activity on Prior DMT (LEMKIDS)

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS)(CONNECT)

Completed:

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (TERIKIDS)

Safety and Efficacy of Fingolimod in Pediatric Patients with Multiple Sclerosis (PARADIGMS)

PK and PD Study of Natalizumab in Pediatric Subjects with RRMS

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

© 2014-2022 IPMSSG | Terms and Privacy Information

Translate »